MENU
SAGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sage Therapeutics (SAGE) Ownership - Who owns Sage Therapeutics?
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
421.76M
P/E Ratio
N/A
Total Cash
504.42M
Projected Growth
N/A
Total Debt
11.84M
Revenue
41.24M
Risk (Beta)
0.24
Dividend Yield
N/A
Total Cash/Share
8.20
Total Debt/Equity
N/A
Revenue/Share
0.68 USD as % of share price
Fundamentals
SAGE
Capitalization
422M
P/E Ratio
N/A
Risk (Beta)
0.24
Dividend Yield
N/A
Total Cash
504M
Total Cash/Share
8.20
Total Debt
11.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.68%
Revenue
41.2M
ROE
N/A
Book Value
465M
P/B Ratio
0.91
Cash Flow
N/A
Earnings
-6.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
7.42
Current Revenue Per Employee
26316.22
Dividends Per Share - Security
N/A
EBITDA
-409.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.38
Revenue To Assets
-56.06
Shares Held By Institutions
401M
Shares Outstanding - Current
61.5M
Total Liabilities
82.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
26.335
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics and medicines for central nervous system disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com